医学临床研究
   Jun. 8, 2025    Home  |  About Journal  |  Editorial Board  |  Instruction  |  Subscribe  |  Advertisement  |  Messages Board  |  Contact Us  |  中文
JOURNAL OF CLINICAL RESEARCH  2020, Vol. 37 Issue (12): 1793-1795    DOI: 10.3969/j.issn.1671-7171.2020.12.009
Current Issue | Archive | Adv Search |
Observation of the Curative Effect of Chinese Medicine Combined with Fimotong in the Treatment of Patients with Premature Ovarian Failure
LU Mei-yan, MA Xiao-hong, AN Pei-xing, et al
Department of Gynecology, Northwest Women and Children's Hospital Family Planning, Shaanxi Xi'an 710061
Download: PDF (0 KB)   HTML (1 KB) 
Export: BibTeX | EndNote (RIS)      
Abstract  【Objective】To study the therapeutic effect of Chinese medicine (Ovarian Zaoshuai Recipe) combined with Fimotong on follicular growth hormone (FSH), serum inhibin B (INHB) and estrogen (E2) in patients with premature ovarian failure. 【Methods】 A total of 102 patients with premature ovarian failure treated in our hospital from August 2015 to August 2018 were divided into two groups according to different treatment methods. The control group was treated with Fimotong, while the observation group was treated with ovariectomy recipe on the basis of Finmotong. The clinical efficacy of the two groups after treatment was analyzed. 【Results】The total effective rate was 92.16% (47/51) in the observation group and 76.47% (39/51) in the control group. The total effective rate in the observation group was higher than that in the control group (P<0.05). There were no significant differences in FSH, INHB and E2 level between the two groups before treatment (P>0.05). However, 3 and 6 months after treatment, serum INHB and E2 levels of the observation group were significantly higher than those of the control group, and the FSH level in the observation was significantly lower than that in the control group. The differences were statistically significant (P<0.05). There was no significant difference in Kupperman score between the two groups before treatment (P>0.05). While the Kupperman score in the observation group was lower than that in the control group at 3 months and 6 months after treatment. The recurrence rate was 9.80% in the observation group and 33.33% (17/51) in the control group. The recurrence rate in the observation group was lower than that in the control group (P<0.05). 【Conclusion】The treatment of premature ovarian failure with Chinese medicine combined with Western medicine can improve the expression of FSH, INHB, and E2, reduce the course of disease, improve the curative effect, and result in a low recurrence rate.
Key wordsPrimary Ovarian Insufficiency/DT      Primary Ovarian Insufficiency/ZD      Drug Therapy, Combination     
Received: 23 September 2019     
PACS:  R711.75  
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
LU Mei-yan
MA Xiao-hong
AN Pei-xing
et al
Cite this article:   
LU Mei-yan,MA Xiao-hong,AN Pei-xing, et al. Observation of the Curative Effect of Chinese Medicine Combined with Fimotong in the Treatment of Patients with Premature Ovarian Failure[J]. JOURNAL OF CLINICAL RESEARCH, 2020, 37(12): 1793-1795.
URL:  
http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2020.12.009     OR     http://journal07.magtech.org.cn/yxlcyj/EN/Y2020/V37/I12/1793
Copyright © Editorial Board of JOURNAL OF CLINICAL RESEARCH
Supported by:Beijing Magtech